ClinicalTrials.Veeva

Menu

Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer

Samsung Medical Center logo

Samsung Medical Center

Status

Enrolling

Conditions

Sarcoma

Study type

Observational

Funder types

Other

Identifiers

NCT01831609
2011-07-089-013

Details and patient eligibility

About

To prospectively collect ascites, pleural fluid, circulating tumor cells and derived primary cultures from metastatic cancer patients. The specimens will be analyzed using DNA/RNA/proteomic approaches.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with histologically confirmed gastrointestinal, genitourinary, sarcoma, rare cancer
  2. Written informed consent
  3. body fluid derived from cancer, available for drainage and collection

Exclusion criteria

  • patients who do not give informed consent form for research use of biomaterials/biospecimens

Trial contacts and locations

1

Loading...

Central trial contact

Jeeyun Lee, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems